| NCT03244020 |
Low Molecular Weight Heparin (LMWH) vs Aspirin for Venous Thromboembolism (VTE) Prophylaxis in Orthopaedic Oncology |
https://ClinicalTrials.gov/show/NCT03244020 |
Enrolling by invitation |
Massachusetts General Hospital |
2023-12-31 |
| NCT04263038 |
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism |
https://ClinicalTrials.gov/show/NCT04263038 |
Recruiting |
University Hospital Inselspital, Berne |
2024-02-29 |
| NCT03339349 |
Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma |
https://ClinicalTrials.gov/show/NCT03339349 |
Completed |
University of Utah |
2019-06-30 |
| NCT03826043 |
THrombo-Embolic Event in Onco-hematology |
https://ClinicalTrials.gov/show/NCT03826043 |
Recruiting |
Centre Antoine Lacassagne |
2022-03-08 |
| NCT03297359 |
WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT03297359 |
Recruiting |
Ottawa Hospital Research Institute |
2022-12-31 |
| NCT03285438 |
REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism. |
https://ClinicalTrials.gov/show/NCT03285438 |
Recruiting |
University Hospital, Brest |
2022-10-09 |
| NCT03276143 |
FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty |
https://ClinicalTrials.gov/show/NCT03276143 |
Completed |
Bayer |
2018-08-20 |
| NCT03266783 |
Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT03266783 |
Recruiting |
Ottawa Hospital Research Institute |
2023-06-30 |
| NCT03259204 |
Swedish Multicenter Trial of Outpatient Prevention of Leg Clots |
https://ClinicalTrials.gov/show/NCT03259204 |
Recruiting |
Karolinska University Hospital |
2020-12-31 |
| NCT03243708 |
Title: Randomized Trial of an EHR Embedded Risk Calculator vs. Standard VTE Prophylaxis for Medical Patients |
https://ClinicalTrials.gov/show/NCT03243708 |
Completed |
The Cleveland Clinic |
2019-04-14 |
| NCT03212365 |
Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery |
https://ClinicalTrials.gov/show/NCT03212365 |
Completed |
University of Utah |
2019-06-02 |
| NCT03197792 |
Perioperative Portal Vein Pulsatility as a Postoperative Prognostic Indicator in Pulmonary Endarterectomy |
https://ClinicalTrials.gov/show/NCT03197792 |
Recruiting |
Centre Chirurgical Marie Lannelongue |
2018-05-24 |
| NCT03185845 |
The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism |
https://ClinicalTrials.gov/show/NCT03185845 |
Recruiting |
Chinese Academy of Medical Sciences, Fuwai Hospital |
2020-12-31 |
| NCT03183063 |
Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events |
https://ClinicalTrials.gov/show/NCT03183063 |
Completed |
William Beaumont Hospitals |
2019-04-23 |
| NCT03158792 |
Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function |
https://ClinicalTrials.gov/show/NCT03158792 |
Completed |
Lebanese American University |
2017-07-13 |
| NCT03129555 |
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE) |
https://ClinicalTrials.gov/show/NCT03129555 |
Recruiting |
Danish Heart Foundation |
2020-03-31 |
| NCT03124017 |
Electronic Alert System for Improving Thromboprophylaxis in Hospitalized Medical Patients |
https://ClinicalTrials.gov/show/NCT03124017 |
Completed |
University Hospital Inselspital, Berne |
2016-03-31 |
| NCT03090880 |
Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) |
https://ClinicalTrials.gov/show/NCT03090880 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-12-31 |
| NCT03088358 |
Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement |
https://ClinicalTrials.gov/show/NCT03088358 |
Completed |
TeaRx LLC |
2015-09-30 |
| NCT03083782 |
Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus |
https://ClinicalTrials.gov/show/NCT03083782 |
Completed |
Thomas Jefferson University |
2017-06-05 |
| NCT03070834 |
RIPT Feasibility Trial |
https://ClinicalTrials.gov/show/NCT03070834 |
Recruiting |
Lawson Health Research Institute |
2020-02-16 |
| NCT03251963 |
Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients |
https://ClinicalTrials.gov/show/NCT03251963 |
Completed |
University of Utah |
2019-03-27 |
| NCT03055026 |
Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer. |
https://ClinicalTrials.gov/show/NCT03055026 |
Recruiting |
Fadoi Foundation, Italy |
2020-12-31 |
| NCT03044574 |
Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT03044574 |
Completed |
Pirogov Russian National Research Medical University |
2018-09-30 |
| NCT02978950 |
SToP: Venous Thromboembolism Screening in the Trauma Population |
https://ClinicalTrials.gov/show/NCT02978950 |
Recruiting |
Intermountain Health Care, Inc. |
2019-12-31 |
| NCT02970032 |
Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin |
https://ClinicalTrials.gov/show/NCT02970032 |
Completed |
University of Utah |
2017-09-10 |
| NCT02969343 |
Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered |
https://ClinicalTrials.gov/show/NCT02969343 |
Completed |
Brigham and Women’s Hospital |
2018-12-31 |
| NCT02958969 |
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma |
https://ClinicalTrials.gov/show/NCT02958969 |
Completed |
Dana-Farber Cancer Institute |
2019-06-30 |
| NCT02945280 |
Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis |
https://ClinicalTrials.gov/show/NCT02945280 |
Recruiting |
Intermountain Health Care, Inc. |
2023-12-31 |
| NCT02935530 |
Thromboprophylaxis After Surgery for Gynecologic Malignancy in China |
https://ClinicalTrials.gov/show/NCT02935530 |
Completed |
Huazhong University of Science and Technology |
2017-08-31 |
| NCT02912234 |
Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants |
https://ClinicalTrials.gov/show/NCT02912234 |
Completed |
Bristol-Myers Squibb |
2016-10-31 |
| NCT02901067 |
STAT-STatin and Aspirin in Trauma |
https://ClinicalTrials.gov/show/NCT02901067 |
Recruiting |
Denver Health and Hospital Authority |
2021-12-31 |
| NCT02870296 |
Anticoagulation Medical Home |
https://ClinicalTrials.gov/show/NCT02870296 |
Completed |
University of Massachusetts, Worcester |
2017-11-03 |
| NCT02864810 |
Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism |
https://ClinicalTrials.gov/show/NCT02864810 |
Completed |
Asan Foundation |
2017-09-09 |
| NCT02864537 |
Self-management of Anticoagulation Treatment |
https://ClinicalTrials.gov/show/NCT02864537 |
Completed |
University of Bergen |
2013-03-31 |
| NCT02853188 |
Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of Lung |
https://ClinicalTrials.gov/show/NCT02853188 |
Completed |
Hopital Foch |
2018-12-20 |
| NCT02832947 |
PK of Rivaroxaban in Bariatric Patients - Extension |
https://ClinicalTrials.gov/show/NCT02832947 |
Completed |
University Hospital Inselspital, Berne |
2016-06-30 |
| NCT02829957 |
RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding |
https://ClinicalTrials.gov/show/NCT02829957 |
Recruiting |
Indiana University |
2025-12-31 |
| NCT02798471 |
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) |
https://ClinicalTrials.gov/show/NCT02798471 |
Recruiting |
Daiichi Sankyo, Inc. |
2020-12-31 |
| NCT02795065 |
Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients |
https://ClinicalTrials.gov/show/NCT02795065 |
Completed |
Al Mouwasat Hospital |
2016-03-31 |
| NCT02785757 |
Cancer-related Thromboembolic Disease |
https://ClinicalTrials.gov/show/NCT02785757 |
Recruiting |
Hospices Civils de Lyon |
2022-02-12 |
| NCT02779400 |
Assessment of a Diagnostic Medical Device for the INR (International Normalized Ratio) Measurement |
https://ClinicalTrials.gov/show/NCT02779400 |
Completed |
University Hospital, Grenoble |
2018-04-14 |
| NCT02774265 |
A Different Approach to Preventing Thrombosis |
https://ClinicalTrials.gov/show/NCT02774265 |
Completed |
University of Maryland, Baltimore |
2017-05-31 |
| NCT02746185 |
Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban |
https://ClinicalTrials.gov/show/NCT02746185 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2018-04-25 |
| NCT02744092 |
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer |
https://ClinicalTrials.gov/show/NCT02744092 |
Active, not recruiting |
Alliance Foundation Trials, LLC. |
2020-06-30 |
| NCT02704052 |
Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose |
https://ClinicalTrials.gov/show/NCT02704052 |
Completed |
University of Utah |
2018-07-31 |
| NCT02687204 |
Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients |
https://ClinicalTrials.gov/show/NCT02687204 |
Completed |
University of Utah |
2017-06-23 |
| NCT02679664 |
StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study |
https://ClinicalTrials.gov/show/NCT02679664 |
Active, not recruiting |
Ottawa Hospital Research Institute |
2020-01-13 |
| NCT02664155 |
Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants |
https://ClinicalTrials.gov/show/NCT02664155 |
Recruiting |
Centre Hospitalier Universitaire de Saint Etienne |
2020-12-31 |
| NCT02616991 |
Computed Tomography CT Venography During Postpartum Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT02616991 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-03-31 |
| NCT02585713 |
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT02585713 |
Completed |
Academic and Community Cancer Research United |
2018-04-02 |
| NCT02583191 |
Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients |
https://ClinicalTrials.gov/show/NCT02583191 |
Recruiting |
AIO-Studien-gGmbH |
2019-12-31 |
| NCT01895777 |
Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE) |
https://ClinicalTrials.gov/show/NCT01895777 |
Completed |
Boehringer Ingelheim |
2019-10-16 |
| NCT02564718 |
Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates |
https://ClinicalTrials.gov/show/NCT02564718 |
Completed |
Bayer |
2017-12-18 |
| NCT02559856 |
Comparison of Bleeding Risk Between Rivaroxaban and Apixaban |
https://ClinicalTrials.gov/show/NCT02559856 |
Completed |
Ottawa Hospital Research Institute |
2017-11-30 |
| NCT02555878 |
A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants |
https://ClinicalTrials.gov/show/NCT02555878 |
Completed |
Janssen Research & Development, LLC |
2018-08-24 |
| NCT02486666 |
Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose |
https://ClinicalTrials.gov/show/NCT02486666 |
Recruiting |
Hamilton Health Sciences Corporation |
2020-12-31 |
| NCT02474212 |
: Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery |
https://ClinicalTrials.gov/show/NCT02474212 |
Recruiting |
Tampere University Hospital |
2020-12-31 |
| NCT02464969 |
Apixaban for the Acute Treatment of Venous Thromboembolism in Children |
https://ClinicalTrials.gov/show/NCT02464969 |
Recruiting |
Pfizer |
2023-04-30 |
| NCT02444572 |
Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® |
https://ClinicalTrials.gov/show/NCT02444572 |
Recruiting |
Les Laboratoires des Médicaments Stériles |
2020-12-31 |
| NCT02438098 |
Rivaroxaban in Bariatric Surgery |
https://ClinicalTrials.gov/show/NCT02438098 |
Completed |
University Hospital Inselspital, Berne |
2015-11-30 |
| NCT02425345 |
Women’s Health Initiative Strong and Healthy Study |
https://ClinicalTrials.gov/show/NCT02425345 |
Active, not recruiting |
Fred Hutchinson Cancer Research Center |
2020-12-31 |
| NCT02412982 |
Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients |
https://ClinicalTrials.gov/show/NCT02412982 |
Recruiting |
University of Cincinnati |
2018-12-31 |
| NCT02411292 |
Enoxaparin Metabolism in Reconstructive Surgery Patients |
https://ClinicalTrials.gov/show/NCT02411292 |
Completed |
University of Utah |
2016-03-31 |
| NCT02402881 |
Education Bundle to Decrease Patient Refusal of VTE Prophylaxis |
https://ClinicalTrials.gov/show/NCT02402881 |
Completed |
Johns Hopkins University |
2018-11-30 |
| NCT02379806 |
The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Study |
https://ClinicalTrials.gov/show/NCT02379806 |
Recruiting |
University Hospital, Brest |
2022-12-31 |
| NCT02376803 |
The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The “INRange” RCT |
https://ClinicalTrials.gov/show/NCT02376803 |
Completed |
University of Alberta |
2016-09-30 |
| NCT02366871 |
Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy |
https://ClinicalTrials.gov/show/NCT02366871 |
Completed |
University of Colorado, Denver |
2019-06-30 |
| NCT02342444 |
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD) |
https://ClinicalTrials.gov/show/NCT02342444 |
Recruiting |
Oregon Health and Science University |
2020-12-31 |
| NCT02334007 |
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery |
https://ClinicalTrials.gov/show/NCT02334007 |
Completed |
McMaster University |
2018-09-30 |
| NCT02309411 |
EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis |
https://ClinicalTrials.gov/show/NCT02309411 |
Completed |
Bayer |
2017-04-05 |
| NCT02303431 |
Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study |
https://ClinicalTrials.gov/show/NCT02303431 |
Recruiting |
Daiichi Sankyo, Inc. |
2020-09-30 |
| NCT02301793 |
Educating Nurses About Venous Thromboembolism (VTE) Prevention |
https://ClinicalTrials.gov/show/NCT02301793 |
Completed |
Johns Hopkins University |
2015-03-31 |
| NCT02295475 |
Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome |
https://ClinicalTrials.gov/show/NCT02295475 |
Active, not recruiting |
Intermountain Health Care, Inc. |
2021-04-30 |
| NCT02271399 |
Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty |
https://ClinicalTrials.gov/show/NCT02271399 |
Completed |
Hanyang University Seoul Hospital |
2016-01-31 |
| NCT02234843 |
EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis |
https://ClinicalTrials.gov/show/NCT02234843 |
Completed |
Bayer |
2019-01-30 |
| NCT02223260 |
Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age |
https://ClinicalTrials.gov/show/NCT02223260 |
Completed |
Boehringer Ingelheim |
2016-01-31 |
| NCT02197416 |
Safety of Dabigatran Etexilate in Blood Clot Prevention in Children |
https://ClinicalTrials.gov/show/NCT02197416 |
Completed |
Boehringer Ingelheim |
2019-10-16 |
| NCT02195232 |
Cancer Associated Thrombosis and Isoquercetin (CATIQ) |
https://ClinicalTrials.gov/show/NCT02195232 |
Active, not recruiting |
Dana-Farber Cancer Institute |
2018-12-31 |
| NCT02186223 |
The Angel® Catheter Pivotal Clinical Trial |
https://ClinicalTrials.gov/show/NCT02186223 |
Completed |
BiO2 Medical |
2015-12-31 |
| NCT02170935 |
Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement Surgery |
https://ClinicalTrials.gov/show/NCT02170935 |
Completed |
Boehringer Ingelheim |
2002-06-30 |
| NCT02170701 |
BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery |
https://ClinicalTrials.gov/show/NCT02170701 |
Completed |
Boehringer Ingelheim |
2001-06-30 |
| NCT02103101 |
Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events |
https://ClinicalTrials.gov/show/NCT02103101 |
Completed |
Centre Hospitalier Universitaire de Besancon |
2017-10-31 |
| NCT02095509 |
Pharmacokinetics of Enoxaparin in Intensive Care Patients |
https://ClinicalTrials.gov/show/NCT02095509 |
Completed |
Tampere University Hospital |
2016-06-30 |
| NCT02073682 |
Cancer Venous Thromboembolism (VTE) |
https://ClinicalTrials.gov/show/NCT02073682 |
Completed |
Daiichi Sankyo, Inc. |
2017-09-15 |
| NCT02070237 |
Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis |
https://ClinicalTrials.gov/show/NCT02070237 |
Completed |
MemorialCare Health System |
2014-03-31 |
| NCT02067182 |
Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation |
https://ClinicalTrials.gov/show/NCT02067182 |
Recruiting |
University Hospital, Bonn |
2020-08-31 |
| NCT02064439 |
Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) |
https://ClinicalTrials.gov/show/NCT02064439 |
Completed |
Bayer |
2016-09-22 |
| NCT01317160 |
Compression Treatment Effects on Complications and Healing of Achilles Tendon Rupture |
https://ClinicalTrials.gov/show/NCT01317160 |
Completed |
Karolinska University Hospital |
2015-08-31 |
| NCT01308528 |
Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery |
https://ClinicalTrials.gov/show/NCT01308528 |
Completed |
Cristália Produtos QuÃmicos Farmacêuticos Ltda. |
2017-02-28 |
| NCT01274637 |
PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot |
https://ClinicalTrials.gov/show/NCT01274637 |
Completed |
Ottawa Hospital Research Institute |
2014-01-31 |
| NCT02048865 |
Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients |
https://ClinicalTrials.gov/show/NCT02048865 |
Completed |
Ottawa Hospital Research Institute |
2018-10-10 |
| NCT01989845 |
Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer |
https://ClinicalTrials.gov/show/NCT01989845 |
Completed |
Seoul National University Hospital |
2016-12-31 |
| NCT01976988 |
Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal Surgery |
https://ClinicalTrials.gov/show/NCT01976988 |
Completed |
Cedars-Sinai Medical Center |
2015-05-31 |
| NCT01976507 |
Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism |
https://ClinicalTrials.gov/show/NCT01976507 |
Completed |
Vanderbilt University Medical Center |
2016-12-31 |
| NCT01938248 |
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation |
https://ClinicalTrials.gov/show/NCT01938248 |
Recruiting |
Population Health Research Institute |
2022-08-31 |
| NCT01935414 |
Geko Neuromuscular Stimulator vs Thromboembolism Deterrent Stockings (TEDS): DVT Prevention Study |
https://ClinicalTrials.gov/show/NCT01935414 |
Active, not recruiting |
Firstkind Ltd |
2016-11-16 |
| NCT01924065 |
Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation |
https://ClinicalTrials.gov/show/NCT01924065 |
Active, not recruiting |
Suleyman Demirel University |
2017-08-31 |
| NCT01869075 |
Toronto Thromboprophylaxis Patient Safety Initiative |
https://ClinicalTrials.gov/show/NCT01869075 |
Completed |
Sunnybrook Health Sciences Centre |
2009-03-31 |
| NCT01857583 |
Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs |
https://ClinicalTrials.gov/show/NCT01857583 |
Completed |
Daiichi Sankyo, Inc. |
2012-12-31 |
| NCT01835990 |
Feasibility Study of Geko vs. IPCs in Trauma |
https://ClinicalTrials.gov/show/NCT01835990 |
Completed |
Hamilton Health Sciences Corporation |
2014-08-31 |
| NCT01747746 |
Anticoagulation With Rivaroxaban in Cardioversion -The ARC Study |
https://ClinicalTrials.gov/show/NCT01747746 |
Completed |
John H. Stroger Hospital |
2014-10-31 |
| NCT01729559 |
Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin |
https://ClinicalTrials.gov/show/NCT01729559 |
Completed |
Scripps Health |
2014-09-30 |
| NCT01727401 |
Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT01727401 |
Active, not recruiting |
G. d’Annunzio University |
2020-12-31 |
| NCT01720108 |
Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty |
https://ClinicalTrials.gov/show/NCT01720108 |
Completed |
Nova Scotia Health Authority |
2016-07-31 |
| NCT01713361 |
Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS-FXIRx in Total Knee Arthroplasty |
https://ClinicalTrials.gov/show/NCT01713361 |
Completed |
Ionis Pharmaceuticals, Inc. |
2014-05-31 |
| NCT01707394 |
Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder |
https://ClinicalTrials.gov/show/NCT01707394 |
Recruiting |
Bristol-Myers Squibb |
2021-05-31 |
| NCT01696760 |
Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology |
https://ClinicalTrials.gov/show/NCT01696760 |
Completed |
Ohio State University Comprehensive Cancer Center |
2012-12-31 |
| NCT01653405 |
Improving Anticoagulation Control in VISN 1 |
https://ClinicalTrials.gov/show/NCT01653405 |
Completed |
VA Office of Research and Development |
2016-09-30 |
| NCT01598805 |
Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts |
https://ClinicalTrials.gov/show/NCT01598805 |
Completed |
University of Zurich |
2012-09-30 |
| NCT01588171 |
Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum |
https://ClinicalTrials.gov/show/NCT01588171 |
Completed |
Hawler Medical University |
2013-10-31 |
| NCT01583218 |
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) |
https://ClinicalTrials.gov/show/NCT01583218 |
Completed |
Portola Pharmaceuticals |
2015-12-31 |
| NCT01573169 |
PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients |
https://ClinicalTrials.gov/show/NCT01573169 |
Recruiting |
University Of Perugia |
2020-12-31 |
| NCT01561885 |
Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through Pathways |
https://ClinicalTrials.gov/show/NCT01561885 |
Completed |
King Abdullah International Medical Research Center |
2016-03-31 |
| NCT01524653 |
Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) |
https://ClinicalTrials.gov/show/NCT01524653 |
Completed |
University of Vermont |
2016-07-01 |
| NCT01513759 |
Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy |
https://ClinicalTrials.gov/show/NCT01513759 |
Completed |
EKOS Corporation |
2013-02-17 |
| NCT01467583 |
Fondaparinux in Critically Ill Patients With Renal Failure |
https://ClinicalTrials.gov/show/NCT01467583 |
Completed |
Wayne State University |
2013-11-30 |
| NCT01463280 |
Effect of Tumescent Lidocaine on Platelet Function |
https://ClinicalTrials.gov/show/NCT01463280 |
Completed |
Klein, Jeffrey A., M.D. |
2013-12-31 |
| NCT01452568 |
Anticoagulant After Implantation of Biological Aortic Valve Comparing With Aspirin |
https://ClinicalTrials.gov/show/NCT01452568 |
Completed |
Rigshospitalet, Denmark |
2012-03-31 |
| NCT01431456 |
Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery |
https://ClinicalTrials.gov/show/NCT01431456 |
Completed |
Martini Hospital Groningen |
2014-10-31 |
| NCT01403090 |
Safety Study of the Angelâ„¢ Catheter in Subjects With Risk of Pulmonary Embolism |
https://ClinicalTrials.gov/show/NCT01403090 |
Completed |
BiO2 Medical |
2012-03-31 |
| NCT01401725 |
Electronic Strategies to Enhance Venous Thromboemboli (VTE) Prophylaxis in Hospitalized Medical Patients |
https://ClinicalTrials.gov/show/NCT01401725 |
Completed |
McMaster University |
2012-06-30 |
| NCT01370278 |
Clearance Of Mucus In Stents (COMIS) |
https://ClinicalTrials.gov/show/NCT01370278 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-06-30 |
| NCT01348074 |
Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist |
https://ClinicalTrials.gov/show/NCT01348074 |
Completed |
McMaster University |
2013-12-31 |
| NCT01344954 |
Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery |
https://ClinicalTrials.gov/show/NCT01344954 |
Completed |
ThromboGenics |
2011-12-31 |
| NCT04444700 |
A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04444700 |
Recruiting |
University of Sao Paulo General Hospital |
2020-10-31 |
| NCT04393909 |
Improving Safety of Diagnosis and Therapy in the Inpatient Setting |
https://ClinicalTrials.gov/show/NCT04393909 |
Recruiting |
Brigham and Women’s Hospital |
2021-06-30 |
| NCT04305756 |
Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery |
https://ClinicalTrials.gov/show/NCT04305756 |
Recruiting |
University of Utah |
2021-07-01 |
| NCT04267718 |
Efficacy of the Use of Risk Scores in Reducing Important Clinical Outcomes in Hospitalized Medical Ill Patients |
https://ClinicalTrials.gov/show/NCT04267718 |
Recruiting |
Fadoi Foundation, Italy |
2020-04-30 |
| NCT04169269 |
Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban |
https://ClinicalTrials.gov/show/NCT04169269 |
Recruiting |
Florida Orthopaedic Institute |
2020-12-31 |
| NCT04157881 |
A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04157881 |
Recruiting |
Population Health Research Institute |
2020-04-30 |
| NCT04141254 |
Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism. |
https://ClinicalTrials.gov/show/NCT04141254 |
Recruiting |
University Hospital, Brest |
2021-12-31 |
| NCT04072068 |
Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy |
https://ClinicalTrials.gov/show/NCT04072068 |
Recruiting |
Gruppo Oncologico Italiano di Ricerca Clinica |
2020-07-31 |
| NCT04066764 |
Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters |
https://ClinicalTrials.gov/show/NCT04066764 |
Recruiting |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
2024-10-01 |
| NCT04041843 |
Oral Anticoagulant Apixaban for Treatment of Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT04041843 |
Recruiting |
New York Medical College |
2020-05-31 |
| NCT04031859 |
Risk Stratification Procedure for Thromboembolism Prophylaxis |
https://ClinicalTrials.gov/show/NCT04031859 |
Completed |
Ministry of Health, Saudi Arabia |
2019-07-14 |
| NCT04022915 |
PET Fibrin Imaging of DVT and PE |
https://ClinicalTrials.gov/show/NCT04022915 |
Recruiting |
Massachusetts General Hospital |
2023-05-13 |
| NCT03988101 |
Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event |
https://ClinicalTrials.gov/show/NCT03988101 |
Recruiting |
Yonsei University |
2021-02-28 |
| NCT03919890 |
A Two-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-7684 in Healthy Adult Volunteers |
https://ClinicalTrials.gov/show/NCT03919890 |
Completed |
Ono Pharmaceutical Co. Ltd |
2019-08-23 |
| NCT03812328 |
Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee Replacement |
https://ClinicalTrials.gov/show/NCT03812328 |
Completed |
Tetherex Pharmaceuticals Corporation |
2019-10-01 |
| NCT03804697 |
Selective Thromboembolism Prophylaxis After Arthroplasty |
https://ClinicalTrials.gov/show/NCT03804697 |
Completed |
Guangdong Provincial People’s Hospital |
2017-08-31 |
| NCT03728166 |
Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT) |
https://ClinicalTrials.gov/show/NCT03728166 |
Recruiting |
Brigham and Women’s Hospital |
2020-11-30 |
| NCT03691753 |
Safety and Efficacy Study of Fitaya Vena Cava Filter |
https://ClinicalTrials.gov/show/NCT03691753 |
Recruiting |
Lifetech Scientific (Shenzhen) Co., Ltd. |
2020-04-30 |
| NCT03678506 |
Apixaban for Extended Anticoagulation (APIDULCIS) |
https://ClinicalTrials.gov/show/NCT03678506 |
Recruiting |
Arianna Anticoagulazione Foundation |
2021-02-28 |
| NCT03636295 |
Low INR to Minimize Bleeding With Mechanical Valves Trial |
https://ClinicalTrials.gov/show/NCT03636295 |
Recruiting |
McMaster University |
2022-09-30 |
| NCT03581877 |
Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE |
https://ClinicalTrials.gov/show/NCT03581877 |
Recruiting |
Northwell Health |
2021-12-31 |
| NCT03559114 |
PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST) |
https://ClinicalTrials.gov/show/NCT03559114 |
Recruiting |
Sunnybrook Health Sciences Centre |
2022-12-31 |
| NCT03516656 |
Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin |
https://ClinicalTrials.gov/show/NCT03516656 |
Active, not recruiting |
University of Utah |
2019-06-30 |
| NCT03424460 |
Venous Thromboembolism in Myotonic Dystrophy Type 1 |
https://ClinicalTrials.gov/show/NCT03424460 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-01-11 |
| NCT01267305 |
The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery |
https://ClinicalTrials.gov/show/NCT01267305 |
Completed |
Shanghai Zhongshan Hospital |
2013-04-30 |
| NCT01234064 |
Graduated Compression Stockings (GCS) Pilot Substudy |
https://ClinicalTrials.gov/show/NCT01234064 |
Completed |
McMaster University |
2011-12-31 |
| NCT01225822 |
BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery |
https://ClinicalTrials.gov/show/NCT01225822 |
Completed |
Boehringer Ingelheim |
2003-08-31 |
| NCT01210755 |
Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics |
https://ClinicalTrials.gov/show/NCT01210755 |
Completed |
University Hospital, Grenoble |
2011-03-31 |
| NCT01206972 |
Dose-confirmatory Bridging Study in Total Knee Replacement |
https://ClinicalTrials.gov/show/NCT01206972 |
Completed |
Bayer |
2011-05-31 |
| NCT01205932 |
Dose-confirmatory Bridging Study in Total Hip Replacement |
https://ClinicalTrials.gov/show/NCT01205932 |
Completed |
Bayer |
2011-06-30 |
| NCT01203098 |
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty |
https://ClinicalTrials.gov/show/NCT01203098 |
Completed |
Daiichi Sankyo, Inc. |
2008-12-31 |
| NCT01203072 |
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty |
https://ClinicalTrials.gov/show/NCT01203072 |
Completed |
Daiichi Sankyo, Inc. |
2007-09-30 |
| NCT01184989 |
Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate |
https://ClinicalTrials.gov/show/NCT01184989 |
Completed |
Boehringer Ingelheim |
2013-04-30 |
| NCT01181167 |
A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty |
https://ClinicalTrials.gov/show/NCT01181167 |
Completed |
Daiichi Sankyo, Inc. |
2010-01-31 |
| NCT01181141 |
Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery |
https://ClinicalTrials.gov/show/NCT01181141 |
Completed |
Daiichi Sankyo, Inc. |
2009-08-31 |
| NCT01181102 |
A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty |
https://ClinicalTrials.gov/show/NCT01181102 |
Completed |
Daiichi Sankyo, Inc. |
2009-09-30 |
| NCT01130025 |
Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer |
https://ClinicalTrials.gov/show/NCT01130025 |
Completed |
LEO Pharma |
2014-04-30 |
| NCT01119300 |
EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin |
https://ClinicalTrials.gov/show/NCT01119300 |
Completed |
Utrecht Institute for Pharmaceutical Sciences |
2013-10-31 |
| NCT01119274 |
EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon |
https://ClinicalTrials.gov/show/NCT01119274 |
Completed |
Utrecht Institute for Pharmaceutical Sciences |
2013-01-31 |
| NCT01119261 |
EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol |
https://ClinicalTrials.gov/show/NCT01119261 |
Completed |
Utrecht Institute for Pharmaceutical Sciences |
2013-06-30 |
| NCT01118299 |
AMPLATZER Cardiac Plug Clinical Trial |
https://ClinicalTrials.gov/show/NCT01118299 |
Completed |
Abbott Medical Devices |
2018-12-06 |
| NCT01094886 |
Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement |
https://ClinicalTrials.gov/show/NCT01094886 |
Completed |
Ortho-McNeil Janssen Scientific Affairs, LLC |
2010-12-31 |
| NCT01083732 |
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age |
https://ClinicalTrials.gov/show/NCT01083732 |
Completed |
Boehringer Ingelheim |
2016-02-29 |
| NCT01068795 |
Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome |
https://ClinicalTrials.gov/show/NCT01068795 |
Completed |
HaEmek Medical Center, Israel |
2015-01-31 |
| NCT01050153 |
The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma |
https://ClinicalTrials.gov/show/NCT01050153 |
Completed |
Denver Health and Hospital Authority |
2011-12-31 |
| NCT01028950 |
YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness |
https://ClinicalTrials.gov/show/NCT01028950 |
Completed |
Astellas Pharma Inc |
2010-04-30 |
| NCT01006876 |
Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation |
https://ClinicalTrials.gov/show/NCT01006876 |
Completed |
Texas Cardiac Arrhythmia Research Foundation |
2013-03-31 |
| NCT01006733 |
Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT |
https://ClinicalTrials.gov/show/NCT01006733 |
Completed |
Washington University School of Medicine |
2016-10-31 |
| NCT00986154 |
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). |
https://ClinicalTrials.gov/show/NCT00986154 |
Completed |
Daiichi Sankyo, Inc. |
2013-04-30 |
| NCT00981409 |
The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients |
https://ClinicalTrials.gov/show/NCT00981409 |
Completed |
GlaxoSmithKline |
2008-12-31 |
| NCT00978445 |
Remote Home Prothrombin Time (PT)/International Normalized Ratio (INR) Monitoring and Patient Management System |
https://ClinicalTrials.gov/show/NCT00978445 |
Completed |
ZIN Technologies, Inc. |
2010-08-31 |
| NCT00968929 |
Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC) |
https://ClinicalTrials.gov/show/NCT00968929 |
Completed |
Beijing Chao Yang Hospital |
2009-05-31 |
| NCT00967304 |
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT00967304 |
Completed |
Ottawa Hospital Research Institute |
2015-01-31 |
| NCT00966277 |
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients |
https://ClinicalTrials.gov/show/NCT00966277 |
Completed |
M.D. Anderson Cancer Center |
2014-09-30 |
| NCT00964275 |
Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a Vein |
https://ClinicalTrials.gov/show/NCT00964275 |
Completed |
University Hospital, Brest |
2014-10-31 |
| NCT00952380 |
Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients |
https://ClinicalTrials.gov/show/NCT00952380 |
Completed |
Pfizer |
2018-03-31 |
| NCT00951574 |
Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium) |
https://ClinicalTrials.gov/show/NCT00951574 |
Completed |
Italfarmaco |
2007-05-31 |
| NCT00942435 |
A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery |
https://ClinicalTrials.gov/show/NCT00942435 |
Completed |
Astellas Pharma Inc |
2010-04-30 |
| NCT00937911 |
Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities |
https://ClinicalTrials.gov/show/NCT00937911 |
Completed |
Astellas Pharma Inc |
2010-04-30 |
| NCT00937820 |
Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT00937820 |
Completed |
Astellas Pharma Inc |
2010-12-31 |
| NCT00927862 |
Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin |
https://ClinicalTrials.gov/show/NCT00927862 |
Completed |
Intermountain Health Care, Inc. |
2010-12-31 |
| NCT00917254 |
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery |
https://ClinicalTrials.gov/show/NCT00917254 |
Completed |
Astellas Pharma Inc |
2010-01-31 |
| NCT00913120 |
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery |
https://ClinicalTrials.gov/show/NCT00913120 |
Completed |
Astellas Pharma Inc |
2010-03-31 |
| NCT00902928 |
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery |
https://ClinicalTrials.gov/show/NCT00902928 |
Completed |
Astellas Pharma Inc |
2010-06-30 |
| NCT00878826 |
Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy. |
https://ClinicalTrials.gov/show/NCT00878826 |
Completed |
Stanford University |
2011-08-31 |
| NCT00853463 |
Discharge ALERT: Quality Improvement Initiative |
https://ClinicalTrials.gov/show/NCT00853463 |
Completed |
Brigham and Women’s Hospital |
2010-03-31 |
| NCT00851864 |
Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing |
https://ClinicalTrials.gov/show/NCT00851864 |
Completed |
University of Calgary |
2010-10-31 |
| NCT00844415 |
Safety and Tolerability of Dabigatran Etexilate in Adolescents |
https://ClinicalTrials.gov/show/NCT00844415 |
Completed |
Boehringer Ingelheim |
2012-02-29 |
| NCT00839826 |
ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial |
https://ClinicalTrials.gov/show/NCT00839826 |
Completed |
Bayer |
2003-11-30 |
| NCT03240120 |
A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT03240120 |
Recruiting |
The University of Hong Kong |
2021-05-31 |
| NCT03045406 |
Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT03045406 |
Active, not recruiting |
Fadoi Foundation, Italy |
2019-06-01 |
| NCT02913326 |
A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT) |
https://ClinicalTrials.gov/show/NCT02913326 |
Completed |
Boehringer Ingelheim |
2018-06-22 |
| NCT04367831 |
Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04367831 |
Recruiting |
Columbia University |
2020-11-30 |
| NCT03244267 |
App Reminder on ASA Adherence |
https://ClinicalTrials.gov/show/NCT03244267 |
Completed |
Emory University |
2019-03-08 |
| NCT04447378 |
Safety of Fondaparinux as Post Partum Thromboprophylaxis |
https://ClinicalTrials.gov/show/NCT04447378 |
Completed |
National University of Malaysia |
2018-06-01 |
| NCT00814177 |
Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients |
https://ClinicalTrials.gov/show/NCT00814177 |
Completed |
McMaster University |
2009-01-31 |
| NCT01565239 |
Fiix-prothrombin Time for Monitoring Warfarin |
https://ClinicalTrials.gov/show/NCT01565239 |
Completed |
Landspitali University Hospital |
2014-02-28 |
| NCT04257487 |
Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) |
https://ClinicalTrials.gov/show/NCT04257487 |
Recruiting |
Arianna Anticoagulazione Foundation |
2023-09-02 |
| NCT03139487 |
A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT03139487 |
Recruiting |
Asan Medical Center |
2021-09-30 |
| NCT02040103 |
Pneumatic Compression for Preventing Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT02040103 |
Completed |
King Abdullah International Medical Research Center |
2018-11-13 |
| NCT04373707 |
Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 |
https://ClinicalTrials.gov/show/NCT04373707 |
Recruiting |
Central Hospital, Nancy, France |
2020-09-30 |
| NCT00794560 |
Self-management of Low Molecular Weight Heparin Therapy |
https://ClinicalTrials.gov/show/NCT00794560 |
Completed |
University Hospital, Basel, Switzerland |
2009-08-31 |
| NCT00793234 |
Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery |
https://ClinicalTrials.gov/show/NCT00793234 |
Completed |
ThromboGenics |
2010-01-31 |
| NCT00790335 |
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis |
https://ClinicalTrials.gov/show/NCT00790335 |
Completed |
Washington University School of Medicine |
2017-01-31 |
| NCT00786474 |
Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study) |
https://ClinicalTrials.gov/show/NCT00786474 |
Completed |
Duke University |
2015-02-28 |
| NCT00781378 |
Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in China |
https://ClinicalTrials.gov/show/NCT00781378 |
Completed |
Beijing Chao Yang Hospital |
2006-02-28 |
| NCT00774748 |
Once Weekly Subcutaneous Ports for the Administration of Anticoagulants |
https://ClinicalTrials.gov/show/NCT00774748 |
Completed |
University of North Carolina, Chapel Hill |
2010-04-30 |
| NCT00773448 |
Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT00773448 |
Completed |
Ottawa Hospital Research Institute |
2015-04-30 |
| NCT00740987 |
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU) |
https://ClinicalTrials.gov/show/NCT00740987 |
Completed |
University Hospital, Brest |
2015-01-31 |
| NCT00740844 |
Efficacy of Intermittent Pneumatic Compression (IPC) on Venous Thromboembolism Incidence in Intensive Care Unit (ICU) Patients With High Bleeding Risk |
https://ClinicalTrials.gov/show/NCT00740844 |
Completed |
University Hospital, Brest |
2011-01-31 |
| NCT00740493 |
Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP) |
https://ClinicalTrials.gov/show/NCT00740493 |
Completed |
University Hospital, Brest |
2017-01-31 |
| NCT00721760 |
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery |
https://ClinicalTrials.gov/show/NCT00721760 |
Completed |
Sanofi |
2009-10-31 |
| NCT00718224 |
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery |
https://ClinicalTrials.gov/show/NCT00718224 |
Completed |
Sanofi |
2009-05-31 |
| NCT00709904 |
Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgery |
https://ClinicalTrials.gov/show/NCT00709904 |
Completed |
Sanofi |
2010-01-31 |
| NCT00703274 |
Preventing Recurrence of Thromboembolic Events Through Coordinated Treatment in the District of Columbia |
https://ClinicalTrials.gov/show/NCT00703274 |
Completed |
Georgetown University |
2013-01-31 |
| NCT00680186 |
Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE) |
https://ClinicalTrials.gov/show/NCT00680186 |
Completed |
Boehringer Ingelheim |
2011-05-31 |
| NCT00697099 |
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery |
https://ClinicalTrials.gov/show/NCT00697099 |
Completed |
Sanofi |
2009-06-30 |
| NCT00694382 |
Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy |
https://ClinicalTrials.gov/show/NCT00694382 |
Completed |
Sanofi |
2010-11-30 |
| NCT00689520 |
Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis |
https://ClinicalTrials.gov/show/NCT00689520 |
Completed |
Hospital Universitari de Bellvitge |
2005-01-31 |
| NCT00679588 |
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery |
https://ClinicalTrials.gov/show/NCT00679588 |
Completed |
Sanofi |
2010-08-31 |
| NCT00657150 |
Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty |
https://ClinicalTrials.gov/show/NCT00657150 |
Completed |
Boehringer Ingelheim |
2009-09-30 |
| NCT00641732 |
Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement |
https://ClinicalTrials.gov/show/NCT00641732 |
Completed |
Takeda |
2008-10-31 |
| NCT00634907 |
Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin) |
https://ClinicalTrials.gov/show/NCT00634907 |
Completed |
University of Utah |
2008-10-31 |
| NCT00629447 |
Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients |
https://ClinicalTrials.gov/show/NCT00629447 |
Completed |
Duke University |
2007-03-31 |
| NCT01304108 |
Improving Venous Thromboembolism Prophylaxis |
https://ClinicalTrials.gov/show/NCT01304108 |
Completed |
Mayo Clinic |
2010-05-31 |
| NCT00571649 |
Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients |
https://ClinicalTrials.gov/show/NCT00571649 |
Completed |
Bayer |
2010-08-31 |
| NCT00558259 |
Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE |
https://ClinicalTrials.gov/show/NCT00558259 |
Completed |
Boehringer Ingelheim |
2011-02-28 |
| NCT00556426 |
Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter. |
https://ClinicalTrials.gov/show/NCT00556426 |
Completed |
C. R. Bard |
2007-04-30 |
| NCT00531843 |
The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients |
https://ClinicalTrials.gov/show/NCT00531843 |
Completed |
University of California, San Francisco |
2008-06-30 |
| NCT00504556 |
A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation |
https://ClinicalTrials.gov/show/NCT00504556 |
Completed |
Daiichi Sankyo, Inc. |
2008-06-30 |
| NCT00799968 |
12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China |
https://ClinicalTrials.gov/show/NCT00799968 |
Completed |
Beijing Chao Yang Hospital |
2006-02-28 |
| NCT00486915 |
Impact of Left Atrial Appendage Exclusion on Short-Term Clinical Outcomes and Long-Term Stroke Incidence |
https://ClinicalTrials.gov/show/NCT00486915 |
Completed |
London Health Sciences Centre |
2008-12-31 |
| NCT00476216 |
Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00476216 |
Completed |
University of Alabama at Birmingham |
2012-12-31 |
| NCT00470626 |
Celect Vena Cava Filter Clinical Trial |
https://ClinicalTrials.gov/show/NCT00470626 |
Completed |
Cook Group Incorporated |
2009-03-31 |
| NCT00462852 |
Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer |
https://ClinicalTrials.gov/show/NCT00462852 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00451412 |
A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients |
https://ClinicalTrials.gov/show/NCT00451412 |
Completed |
Novartis |
2009-06-30 |
| NCT00439725 |
Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study |
https://ClinicalTrials.gov/show/NCT00439725 |
Completed |
Bayer |
2009-08-31 |
| NCT00432796 |
PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin. |
https://ClinicalTrials.gov/show/NCT00432796 |
Active, not recruiting |
Lawson Health Research Institute |
2019-03-31 |
| NCT00408239 |
Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement |
https://ClinicalTrials.gov/show/NCT00408239 |
Completed |
Astellas Pharma Inc |
2009-03-31 |
| NCT00402467 |
An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study |
https://ClinicalTrials.gov/show/NCT00402467 |
Completed |
Bayer |
2004-11-30 |
| NCT00398905 |
Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement |
https://ClinicalTrials.gov/show/NCT00398905 |
Completed |
Bayer |
NA |
| NCT00396786 |
Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement |
https://ClinicalTrials.gov/show/NCT00396786 |
Completed |
Bayer |
2005-07-31 |
| NCT00395772 |
Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis |
https://ClinicalTrials.gov/show/NCT00395772 |
Completed |
Bayer |
NA |
| NCT00353678 |
Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2) |
https://ClinicalTrials.gov/show/NCT00353678 |
Completed |
Astellas Pharma Inc |
2007-08-31 |
| NCT00381888 |
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer |
https://ClinicalTrials.gov/show/NCT00381888 |
Completed |
Masonic Cancer Center, University of Minnesota |
2009-01-31 |
| NCT00375609 |
Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT) |
https://ClinicalTrials.gov/show/NCT00375609 |
Completed |
Portola Pharmaceuticals |
2007-01-31 |
| NCT00371501 |
Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00371501 |
Completed |
Tuen Mun Hospital |
2009-12-31 |
| NCT00362492 |
Safety Study of Stopping Thromboprophylaxis Based on Ultrasound Results After Total Knee Replacement |
https://ClinicalTrials.gov/show/NCT00362492 |
Completed |
University Hospital, Caen |
NA |
| NCT00362232 |
Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement. |
https://ClinicalTrials.gov/show/NCT00362232 |
Completed |
Bayer |
2007-01-31 |
| NCT00361894 |
Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement. |
https://ClinicalTrials.gov/show/NCT00361894 |
Completed |
Bayer |
2007-01-31 |
| NCT00361647 |
Screening for Occult Malignancy in Idiopathic Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT00361647 |
Completed |
University of Padova |
2008-05-31 |
| NCT00338897 |
Dose Ranging Study in Elective Total Hip Replacement Surgery |
https://ClinicalTrials.gov/show/NCT00338897 |
Completed |
Sanofi |
2007-05-31 |
| NCT00333021 |
Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients |
https://ClinicalTrials.gov/show/NCT00333021 |
Completed |
GlaxoSmithKline |
NA |
| NCT00332020 |
Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement |
https://ClinicalTrials.gov/show/NCT00332020 |
Completed |
Bayer |
2007-05-31 |
| NCT00331838 |
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery |
https://ClinicalTrials.gov/show/NCT00331838 |
Completed |
Sanofi |
2007-06-30 |
| NCT00329628 |
Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin |
https://ClinicalTrials.gov/show/NCT00329628 |
Completed |
Bayer |
2007-03-31 |
| NCT00329238 |
Secondary Prevention of Venous Thrombo Embolism (VTE). |
https://ClinicalTrials.gov/show/NCT00329238 |
Completed |
Boehringer Ingelheim |
2010-10-31 |
| NCT00328939 |
ARIXTRA Local Study For Registration In China. |
https://ClinicalTrials.gov/show/NCT00328939 |
Completed |
GlaxoSmithKline |
NA |
| NCT00320424 |
Hip Fracture Study of GSK576428 (Fondaparinux Sodium) |
https://ClinicalTrials.gov/show/NCT00320424 |
Completed |
GlaxoSmithKline |
2006-10-26 |
| NCT00320255 |
A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer |
https://ClinicalTrials.gov/show/NCT00320255 |
Completed |
Bristol-Myers Squibb |
2009-01-31 |
| NCT00291330 |
Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT00291330 |
Completed |
Boehringer Ingelheim |
2009-05-31 |
| NCT00265993 |
Enoxaparin in Acute Venous Thromboembolic Disease |
https://ClinicalTrials.gov/show/NCT00265993 |
Completed |
Sanofi |
2009-01-31 |
| NCT00264277 |
D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT00264277 |
Completed |
St. Orsola Hospital |
2004-12-31 |
| NCT00260988 |
A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery |
https://ClinicalTrials.gov/show/NCT00260988 |
Completed |
Ottawa Hospital Research Institute |
2008-11-30 |
| NCT00246025 |
A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery. |
https://ClinicalTrials.gov/show/NCT00246025 |
Completed |
Boehringer Ingelheim |
2007-06-30 |
| NCT00244725 |
Odiparcil For The Prevention Of Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT00244725 |
Completed |
GlaxoSmithKline |
2006-09-30 |
| NCT00244426 |
S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation |
https://ClinicalTrials.gov/show/NCT00244426 |
Completed |
Pfizer |
2008-04-30 |
| NCT00219973 |
CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation) |
https://ClinicalTrials.gov/show/NCT00219973 |
Completed |
Rovi Pharmaceuticals Laboratories |
NA |
| NCT00205400 |
Comparison of Patient Outcomes Using Different Delivery Models of Anticoagulation Care |
https://ClinicalTrials.gov/show/NCT00205400 |
Completed |
University of Wisconsin, Madison |
2005-03-31 |
| NCT00203658 |
Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin |
https://ClinicalTrials.gov/show/NCT00203658 |
Completed |
University of Calgary |
NA |
| NCT00203580 |
Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) |
https://ClinicalTrials.gov/show/NCT00203580 |
Completed |
University of Calgary |
NA |
| NCT00196118 |
Study of IVC Filter Retrieval With the Günther Tulip Vena Cava Filter |
https://ClinicalTrials.gov/show/NCT00196118 |
Completed |
Cook Group Incorporated |
NA |
| NCT00182403 |
Fixed Dose Heparin Study |
https://ClinicalTrials.gov/show/NCT00182403 |
Completed |
McMaster University |
NA |
| NCT00182364 |
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot) |
https://ClinicalTrials.gov/show/NCT00182364 |
Completed |
McMaster University |
NA |
| NCT00182221 |
Safety of a Diagnostic Strategy With D-Dimer Testing for PE |
https://ClinicalTrials.gov/show/NCT00182221 |
Completed |
McMaster University |
2008-02-29 |
| NCT00182143 |
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT) |
https://ClinicalTrials.gov/show/NCT00182143 |
Completed |
McMaster University |
2010-06-30 |
| NCT00168818 |
Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery |
https://ClinicalTrials.gov/show/NCT00168818 |
Completed |
Boehringer Ingelheim |
2006-07-31 |
| NCT00168805 |
RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery |
https://ClinicalTrials.gov/show/NCT00168805 |
Completed |
Boehringer Ingelheim |
2006-05-31 |
| NCT00152971 |
Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement |
https://ClinicalTrials.gov/show/NCT00152971 |
Completed |
Boehringer Ingelheim |
2006-06-30 |
| NCT00139815 |
Michelangelo - Oasis 5 |
https://ClinicalTrials.gov/show/NCT00139815 |
Completed |
GlaxoSmithKline |
2005-12-31 |
| NCT00135876 |
Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients |
https://ClinicalTrials.gov/show/NCT00135876 |
Completed |
Ontario Clinical Oncology Group (OCOG) |
NA |
| NCT00119457 |
Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial) |
https://ClinicalTrials.gov/show/NCT00119457 |
Completed |
vTv Therapeutics |
NA |
| NCT00077805 |
PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin) |
https://ClinicalTrials.gov/show/NCT00077805 |
Completed |
Sanofi |
2006-07-31 |
| NCT00077753 |
EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization |
https://ClinicalTrials.gov/show/NCT00077753 |
Completed |
Sanofi |
2006-10-31 |
| NCT00014352 |
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00014352 |
Completed |
Memorial Sloan Kettering Cancer Center |
2003-03-31 |
| NCT00064428 |
OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial Infarction |
https://ClinicalTrials.gov/show/NCT00064428 |
Completed |
GlaxoSmithKline |
2006-02-28 |
| NCT00071032 |
Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease |
https://ClinicalTrials.gov/show/NCT00071032 |
Completed |
Rutgers, The State University of New Jersey |
2009-05-31 |
| NCT00024297 |
Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters |
https://ClinicalTrials.gov/show/NCT00024297 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00020189 |
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00020189 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00041509 |
ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST) |
https://ClinicalTrials.gov/show/NCT00041509 |
Completed |
GlaxoSmithKline |
2003-05-31 |
| NCT00038961 |
A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO). |
https://ClinicalTrials.gov/show/NCT00038961 |
Completed |
GlaxoSmithKline |
2004-10-31 |
| NCT00796692 |
Nadroparin for the Initial Treatment of Pulmonary Thromboembolism |
https://ClinicalTrials.gov/show/NCT00796692 |
Completed |
Beijing Chao Yang Hospital |
2006-02-28 |
| NCT00007085 |
Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED II) |
https://ClinicalTrials.gov/show/NCT00007085 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
2004-12-31 |
| NCT00000614 |
Prevention of Recurrent Venous Thromboembolism (PREVENT) |
https://ClinicalTrials.gov/show/NCT00000614 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |